Raia Drogasil S.A. (RADLY)
OTCMKTS · Delayed Price · Currency is USD
2.420
-0.390 (-13.88%)
May 16, 2025, 11:24 AM EDT

Raia Drogasil Statistics

Total Valuation

Raia Drogasil has a market cap or net worth of 4.59 billion. The enterprise value is 5.87 billion.

Market Cap 4.59B
Enterprise Value 5.87B

Important Dates

The last earnings date was Tuesday, May 6, 2025.

Earnings Date May 6, 2025
Ex-Dividend Date May 1, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -1.63%
Shares Change (QoQ) +0.30%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 856.18M

Valuation Ratios

The trailing PE ratio is 22.42 and the forward PE ratio is 23.55.

PE Ratio 22.42
Forward PE 23.55
PS Ratio 0.66
PB Ratio 4.05
P/TBV Ratio 5.89
P/FCF Ratio 20.25
P/OCF Ratio 9.93
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.29, with an EV/FCF ratio of 25.89.

EV / Earnings 28.66
EV / Sales 0.84
EV / EBITDA 8.29
EV / EBIT 14.24
EV / FCF 25.89

Financial Position

The company has a current ratio of 1.34, with a Debt / Equity ratio of 1.19.

Current Ratio 1.34
Quick Ratio 0.39
Debt / Equity 1.19
Debt / EBITDA 1.92
Debt / FCF 5.94
Interest Coverage 2.84

Financial Efficiency

Return on equity (ROE) is 18.68% and return on invested capital (ROIC) is 10.72%.

Return on Equity (ROE) 18.68%
Return on Assets (ROA) 6.76%
Return on Invested Capital (ROIC) 10.72%
Return on Capital Employed (ROCE) 18.17%
Revenue Per Employee 104,780
Profits Per Employee 3,089
Employee Count 64,758
Asset Turnover 1.84
Inventory Turnover 3.45

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.24, so Raia Drogasil's price volatility has been lower than the market average.

Beta (5Y) 0.24
52-Week Price Change -50.00%
50-Day Moving Average 3.31
200-Day Moving Average 4.09
Relative Strength Index (RSI) 31.75
Average Volume (20 Days) 11,615

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Raia Drogasil had revenue of 6.94 billion and earned 204.73 million in profits. Earnings per share was 0.12.

Revenue 6.94B
Gross Profit 2.05B
Operating Income 408.37M
Pretax Income 233.03M
Net Income 204.73M
EBITDA 534.53M
EBIT 408.37M
Earnings Per Share (EPS) 0.12
Full Income Statement

Balance Sheet

The company has 82.01 million in cash and 1.35 billion in debt, giving a net cash position of -1.26 billion.

Cash & Cash Equivalents 82.01M
Total Debt 1.35B
Net Cash -1.26B
Net Cash Per Share n/a
Equity (Book Value) 1.13B
Book Value Per Share 0.66
Working Capital 586.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 462.18 million and capital expenditures -235.55 million, giving a free cash flow of 226.64 million.

Operating Cash Flow 462.18M
Capital Expenditures -235.55M
Free Cash Flow 226.64M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 29.57%, with operating and profit margins of 5.88% and 2.95%.

Gross Margin 29.57%
Operating Margin 5.88%
Pretax Margin 3.36%
Profit Margin 2.95%
EBITDA Margin 7.70%
EBIT Margin 5.88%
FCF Margin 3.26%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.25%.

Dividend Per Share 0.05
Dividend Yield 2.25%
Dividend Growth (YoY) 33.16%
Years of Dividend Growth n/a
Payout Ratio 40.42%
Buyback Yield 1.63%
Shareholder Yield 3.88%
Earnings Yield 4.46%
FCF Yield 4.94%
Dividend Details

Stock Splits

The last stock split was on October 1, 2020. It was a forward split with a ratio of 5.

Last Split Date Oct 1, 2020
Split Type Forward
Split Ratio 5

Scores

Raia Drogasil has an Altman Z-Score of 3.98.

Altman Z-Score 3.98
Piotroski F-Score n/a